Hana Pharm Co Ltd
KRX:293480
Intrinsic Value
The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 15 143.78 KRW. Compared to the current market price of 10 250 KRW, Hana Pharm Co Ltd is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hana Pharm Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Hana Pharm Co Ltd
Balance Sheet Decomposition
Hana Pharm Co Ltd
Current Assets | 100.8B |
Cash & Short-Term Investments | 5.2B |
Receivables | 43B |
Other Current Assets | 52.7B |
Non-Current Assets | 250.2B |
Long-Term Investments | 69.8B |
PP&E | 158.6B |
Intangibles | 15.5B |
Other Non-Current Assets | 6.4B |
Free Cash Flow Analysis
Hana Pharm Co Ltd
KRW | |
Free Cash Flow | KRW |
Earnings Waterfall
Hana Pharm Co Ltd
Revenue
|
225.3B
KRW
|
Cost of Revenue
|
-84B
KRW
|
Gross Profit
|
141.3B
KRW
|
Operating Expenses
|
-116.1B
KRW
|
Operating Income
|
25.2B
KRW
|
Other Expenses
|
-3.9B
KRW
|
Net Income
|
21.3B
KRW
|
Profitability Score
Profitability Due Diligence
Hana Pharm Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Hana Pharm Co Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Hana Pharm Co Ltd's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Hana Pharm Co Ltd
According to Wall Street analysts, the average 1-year price target for Hana Pharm Co Ltd is 18 360 KRW with a low forecast of 18 180 KRW and a high forecast of 18 900 KRW.
Dividends
Current shareholder yield for Hana Pharm Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hana Pharm Co Ltd stock under the Base Case scenario is 15 143.78 KRW.
Compared to the current market price of 10 250 KRW, Hana Pharm Co Ltd is Undervalued by 32%.